In recent years, emerging evidence has shown that the JAK–signal transducer and activator of transcription (STAT) signaling pathway, known for its role in inflammatory response, is involved in NE lineage plasticity in prostate cancer, presenting significant therapeutic potential.24, 142. This evidence concerns the gene SOAT1 and prostate cancer.